Dr. Larry Kosinski on SonarMD: A Platform for IBD Which Significantly Reduces Hospitalizations

Recently, SonarMD announced positive results at Digestive Disease Week® from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) - defined as people living with ulcerative colitis or Crohn’s disease -- and enrolled in the company’s end-to-end, digital care coordination program. In both studies, SonarMD participants experienced a statistically significant and substantial decline in Emergency Department visits and In-patient Admissions compared to risk-matched control groups.
DocWire News spoke with Dr. Larry Kosinski, MD, gastroenterologist and SonarMD Founder & Board Member, to learn more about the company and how its technology stands to benefit patients with IBD.